Amphastar Pharmaceuticals Inc

$20.09
Market Cap 911.49M
ROE 10.2%
Gross Margin 41.1%
Debt/Equity 0.9
Current Ratio 3.9
Revenue QoQ 0.4%
EPS QoQ -0.7%
F-Score 4

About

Amphastar is a biopharmaceutical company that focuses on developing, manufacturing, and commercializing technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the Company sells active pharmaceutical ingredients, or API products. Most of the Company's finished products are contracted and distributed through group purchasing organizations, drug wholesalers, and drug retailers.

Exchange
NASDAQ
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Sector context

Healthcare

Undervalued

Trading at a discount to sector peers

P/E
11.76
vs median 15.30
P/B
1.20
vs median 3.49
ROE
0.10
vs median 0.21

Lower quality - review fundamentals carefully

Small-cap company with higher volatility

Similar companies

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics